Background: Allergic sensitization is associated with eczema, asthma, and rhinitis.
| MATERIAL AND METHODS

| The Isle of wight study cohort
The birth cohort in this study was composed of children born 
| Assessment of allergic diseases and data collection
Detailed questionnaires, resembling the questionnaire of the International Study of Asthma and Allergy in Childhood (ISAAC), were given at age of 4 years (before the publication of the ISAAC questionnaire). A participant was determined to have asthma if she/he had experienced recurrent wheezing in the last 12 months and either given a clinical diagnosis of asthma with or without treated with asthma medications. Eczema was defined as chronic or chronically relapsing itchy dermatitis lasting more than 6 weeks with characteristic morphology and distribution. 17 Diagnosis of rhinitis required at least two of three recurrent nasal discharge, blockage, sneezing, and/or eye symptoms. 18 At the ages of 10 and 18 years, questionnaires including the ISAAC questions were administered. In the case that parents or participants could not attend a follow-up visit to complete the questionnaire, a modified version was given either over the telephone or via postal service. Asthma was defined as "ever had asthma" and "wheezing or whistling in the chest in the last 12 months" or "current treatment for asthma." Eczema diagnosis was as described for age 4 years. Rhinitis was defined by a positive response to ISAAC questions, "in the past 12 months have you had a problem with sneezing, or a runny or blocked nose when you did not have a cold or the flu?"
The outcome considered in our study was single occurrence or comorbidity of asthma, rhinitis, and/or eczema. The questionnaires were used to determine each subject's status for each disease at each age, denoted henceforth as allergic diseases. For each of the three outcomes, disease status was treated as a binary variable (yesno), so at each age, a participant was classified either as disease free or as experiencing one or more of the diseases.
| Definitions on allergic sensitization and allergic disease transitions
Allergic sensitization was defined as a positive skin prick test (SPT) (weal size ≥ 3 mm larger than negative control) to one or more common allergens at 4, 10, and 18 years. The allergens tested were as follows: indoor allergens (house dust mite, dog, cat, Cladosporium, and Alternaria), outdoor allergens (grass, tree-tree at ages 10 and 18 only), and food allergens (soy, milk, egg, cod, and peanut).
Two transition periods were considered, from ages 4 to 10 years and from 10 to 18 years. In each period, four allergic sensitization transition statuses were considered: acquisition of allergic ZHANG ET AL.
| 569 sensitization (non-atopic to atopic), persistence (atopic at both timepoints), remission (atopic to non-atopic), and non-atopic at both time-points. Transitions of allergic disease status were also defined within these two transition periods ( Figure 1 ). Acquisition (positive transition) of allergic disease was defined as a previously healthy patient newly diagnosed with one or more disease (asthma, eczema, and/or rhinitis). Persistence referred to an existing diagnosis that continues across a transition point. Remission (negative transition) occurred when a subject who was previously diagnosed with a disease was disease free at a subsequent follow-up. Participants were measured three times throughout childhood, thus persistence means having a disease at two (or more) consecutive measurements and remission means having the disease at one follow-up age (4 or 10 years) but outgrowing it by the next follow-up age (10 or 18, correspondingly) ( Figure 1 ).
| Statistical analyses
We calculated attritions at each age (4, 10, and 18 years) for the whole cohort. Descriptive statistics were calculated for allergic disorders and allergic sensitizations including counts and percentages. To assess whether the study samples reasonably represented the samples in the complete cohort at each age, at each age, we assessed the consistency of main characteristics of subjects between subjects in the study and subjects in the whole cohort, including allergic disorders, atopy, and representing covariates including gender, as well as paternal and maternal allergic disorders. One sample proportion tests were applied to assess the consistency.
We first assessed the association of allergic disorders at each age with allergic sensitization at that age. We also differentiated between different types of allergic sensitizations, specifically,
Incidence Model
Persistence Model To examine associations between transitions, logistic regression models with repeated measures were used to assess the association between allergic disorders transition over different periods (4-10 and 10-18) and risk factors. This model was applied to each of the three types of transitions, acquisition, remission, and persistence, noted above. For acquisition, we focused on participants who were disease free at the starting age of the transition, that is ages 4 or 10 years;
for remission and persistence, data of participants who had experienced at least one of the three diseases (asthma, eczema, or rhinitis)
at ages 4 or 10 were included in the analyses ( Figure 1 ). The main independent variable was the transition statuses of allergic sensitization during these two periods (4 to 10 and then 10 to 18 years of age). We included the same covariates and potential confounders described previously. In addition, the transition period was also included in the model as a covariate to assess whether one transition period was more important than the other in the pathway of allergic disease transition.
We also implemented logistic regressions to examine the association of allergic sensitization transition at an earlier period with allergic disease transition at a later period (time-lagged model). In particular, we examined the association of sensitization transition from 4 to 10 years of age with allergic disease transition from 10 to 18 years of age. SAS 9.2 PROC GENMOD (SAS Institute Inc., Cary, NC, USA) was used for modelling, with a binomial distribution and a logit link function. Multiple testing was adjusted using the Bonferroni approach with an experiment-wise significance level of 0.05.
| RESULTS
The retentions of the IoW cohort were high at all follow-ups. Specifically, at ages 4, 10, and 18 years of age, the retention percentages were 79%, 89%, and 85%, respectively. Descriptive analysis showed that at age 4, the most common disease was asthma, but at age 10, it was rhinitis and this remained true throughout the remainder of childhood ( Table 1) . Prevalence of asthma-only, rhinitis-only, asthma and rhinitis, eczema and rhinitis, and all three diseases together increased across childhood. Likewise, the prevalence of allergic sensitization (positive SPT) also increased across childhood in both subjects with allergic diseases as well as those without, though as expected, allergic sensitization was much lower among disease-free children at all ages ( Table 2 ). Given the focus of the study, subjects missing transition status for allergic conditions or for atopy were excluded from subsequent analyses. We compared the subsamples with the complete cohort on main characteristics of interest, including allergic disorders, atopy (being allergic to at least one allergen), and covariates including gender, as well as paternal and maternal allergic disorders. After adjusting for multiple testing, the subsamples did not show any statistically significant differences compared to the cohort (Table 3) .
At each follow-up, we examined the association between allergic diseases with atopy status via logistic regressions. We also tested the association for each type of allergic sensitizations (SPT positive T A B L E 1 Allergic disorders at ages of 4, 10, and 18 yrs, %(n) for aeroallergens alone, both aeroallergens and food allergens, or any allergens). Compared to children not sensitized to any allergen, the risk of having allergic diseases was higher at all ages among children allergic to one or more allergens, but the risk of allergic diseases for children allergic to both aeroallergen and food allergen increased substantially from ages 4 years to 18 years ( Figure 2 and Tables S1
to S6).
Using logistic regressions with repeated measures, we tested the association of disease transition with the aforementioned covariates.
Among children who did not have allergic diseases at ages 4 or 10, the odds of acquisition of any allergic disorder among subjects who experienced allergic sensitization acquisition was 3.27 times the odds (P < .0001) for those who were not sensitized (Table 4) . Among children with persistent allergic sensitization, the odds of new diagnosis (acquisition) was 6.32 times the odds (P < .0001) of those without allergic sensitization. Children whose mothers reported history of one or more allergic disorders tended to have higher odds of allergic disorder acquisition (OR= 1.55, P = .038) compared to children whose mothers reported being disease free, although the finding was not statistically significant after adjusting for multiple testing.
On the other hand, it was observed that children whose father had a history of allergic disorder also had higher odds of acquisition (OR=2.02 with P-value .0015) ( Table 4 ).
The odds of persistent allergic disease among subjects who acquired allergic sensitization was 5.49 times the odds for those without allergic sensitization (P = .0001), and the odds of persistent allergic disease was 11.79 times as high among those who had persistent allergic sensitization (P < .0001; Table 5 ). Consequently, the odds of remission among children who experienced allergic sensitization acquisition was lower compared to children who were free of allergic sensitization (OR= 0.18, P = .0001). The odds of remission among children who experienced persistent allergic sensitization was much lower, 0.085 times the odds for children not sensitized (P < .0001; Table 6 ).
Findings from the time-lagged model revealed similar patterns. In particular, among children who did not have allergic diseases at ages 4 or 10, the odds of acquisition of allergic disorder at a later age (10 or 18 years) among subjects who experienced allergic sensitization acquisition at an earlier age (4 to 10 years) was 5.46 times the odds (P = .001) for those who were not sensitized. Among children with persistent allergic sensitization, the odds of acquisition was 5.51
times the odds of those with no sensitization (Table 7) . Season of birth was potentially associated with transition of allergy-related diseases.
In line with what we have previously reported in the cohort, 19 compared to children born in autumn, children born in the season of winter had a lower odds of allergic disease acquisition (OR=0.53, P = .024), while children born in summer tended to have a higher odds (OR=1.66, P = .031), although both associations did not meet the statistical significance threshold after multiple testing correction (Table 7) . Parental history of allergic disorder did not show a statistically significant association with acquisition ( Table 7 ). The odds of persistent allergic diseases from 10 to 18 among subjects who acquired allergic sensitization at 4 or 10 was 4.17 times the odds for those with no sensitization (P = .008), and the odds of persistent disease from 10 to 18 years was 11.31 times as high among those who had earlier age (4-10 years) persistent allergic sensitization (P < .0001; Table 8 ). Although not statistically significant after adjusting for multiple testing, sex was potentially associated with allergic disease transition. In particular, males tended to be less likely to have persistent allergic disease from 10 to 18 compared to girls (OR=0.43, P = .029; Table 8 ), and consequently, more likely to have allergic disease remissions from 10 to 18 years (OR=2.33, P = .029) compared to girls ( Table 9 ). The odds of remission among children who experienced allergic sensitization acquisition at an earlier age was lower compared to unsensitized children (OR= 0.23, P = .008), and the odds of remission among children who had persistent allergic sensitization at an earlier age was much lower, 0.088 times the odds for non-atopic children (P < .0001; Table 9 ). Previously, the development of allergic disease during childhood and its association with allergic sensitization was considered to progress from food allergy and eczema in early childhood to asthma and rhinitis in later childhood, termed the "atopic or allergic march". 20 However, this concept may be an oversimplification as recent studies using birth cohorts suggest an absence of a typical "atopic march" in the majority of children. 21, 22 It is now recognized that at the population level, asthma, rhinitis, and eczema occur as allergic comorbidity clusters [22] [23] [24] with the coexisting allergies becoming increasingly common throughout childhood. 24 Using a consortium of birth cohorts, Bousquet et al 25 proposed that sensitization to multiple allergens further increases the risk of allergic comorbidity. In this analysis, we focused on any allergic sensitization and did not distinguish between subjects sensitized to different allergens.
| DISCUSSION
Asthma, rhinitis, and eczema are manifestations of a common underlying immune disorder with T-helper 2 (Th2) dominance resulting in production of IgE to specific allergens. 25 Development of allergic sensitization increases the risk of subsequent development of relevant clinical disease. 26 However, not all those with allergic sensitization develop allergic conditions and conversely not everyone with asthma, eczema, and rhinitis manifest allergic sensitization. 27 The Genetic factors may underpin both allergic sensitization (positive SPT) and allergic conditions, and, hence, we found parental history of allergy as a major risk factor for acquisition or persistence of allergic disease. This is in line with the findings of the German multicenter asthma study, which recently showed that parental allergies predicted the development of allergic multimorbidity throughout childhood. 24 Further studies are required to investigate how maternal and paternal allergy and allergic sensitization interact to cause allergic comorbidity from childhood to adulthood. Our study had some limitations. The dynamic associations between allergic sensitization and diseases, we have described during childhood, may not be applicable to adulthood as previous cross-sectional studies indicate that allergic conditions in adults are often non-atopic. 28, 29 We used positive SPT to at least one of multiple allergens to assess allergic sensitization, as we do not have specific IgE assessment in all subjects in the cohort to allow a meaningful analysis. Although these two tests reflect the same atopic predisposition and are correlated, epidemiologic studies indicate that there is significant disagreement between the two tests. 30 Using specific IgE may reveal different associations, as they may not have the same biological and clinical relevance. 31 We did not include infancy in our longitudinal trajectory for two reasons. First, we did not have skin prick tests in all children at the one-and two-year assessments. Secondly, asthma and rhinitis are impossible to differentiate from respiratory symptoms associated with viral infections. By four years of age, the phenotype is stable enough to make a reasonable assessment, although a later assessment at five or six years would have been more robust. We also did not include food allergy as an allergic condition as the numbers of children with food allergy were small and other studies have looked at the association of individual food allergy with specific food allergic sensitization. 32 In conclusion, our study shows that natural remission and relapse occurs commonly in both allergic sensitization and clinic allergic manifestations and that these phenotypes are closely associated with each other, such that being persistent in allergic sensitization increases the risk of persistent allergic disease and sensitization remission promotes growing out of allergic conditions throughout childhood. Furthermore, this association was confirmed in a timelagged manner so that remission in allergic sensitization at an earlier age promoted remission in clinical disease at a later time-point. This has important implications for allergy prevention, as inducing 
